Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 GBX | -2.17% | -.--% | -3.57% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Performance
1 day | -2.17% | ||
6 months | -36.92% | ||
Current year | -3.57% | ||
1 year | -58.59% | ||
3 years | -97.71% | ||
5 years | -98.85% | ||
10 years | -98.94% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-2.17% | -.--% | -3.57% | -58.59% | 2.41M | ||
+0.66% | -2.31% | +23.37% | -8.28% | 46.71B | ||
+1.19% | +3.13% | +48.83% | -8.96% | 41.8B | ||
+0.58% | +3.18% | -0.94% | +23.22% | 41.52B | ||
-2.52% | +0.37% | -5.86% | +16.81% | 29.55B | ||
+1.06% | +4.64% | +11.29% | +68.33% | 25.78B | ||
-0.60% | +0.71% | -20.92% | -27.17% | 19.26B | ||
+3.35% | +5.33% | +3.20% | -1.79% | 12.14B | ||
-2.21% | +0.09% | -2.67% | +22.73% | 12.08B | ||
+2.99% | +2.08% | +30.23% | +94.80% | 11.98B | ||
+1.90% | +3.07% | +20.99% | +26.93% | 11.58B | ||
+1.49% | +2.11% | -2.66% | -6.14% | 9.53B | ||
-0.40% | +1.25% | +17.45% | +99.78% | 6.81B | ||
-0.98% | +1.37% | +25.00% | -21.72% | 6.71B | ||
-0.18% | +1.08% | +8.70% | -33.85% | 6.69B | ||
-2.24% | -4.44% | +30.58% | +48.67% | 6.53B | ||
Average | +0.12% | +1.10% | +11.44% | +14.67% | ||
Weighted average by Cap. | +0.37% | +1.61% | +13.65% | +14.56% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -3.57% | ||
2023 | -60.00% | ||
2022 | -89.33% | ||
2021 | -0.61% | ||
2020 | -44.44% | ||
2019 | +203.06% | ||
2018 | -73.87% | ||
2017 | -28.57% | ||
2016 | -12.50% | ||
2015 | -14.29% | ||
2014 | +16.47% | ||
2013 | +50.25% | ||
2012 | -54.80% | ||
2011 | -31.40% | ||
2010 | +6.61% | ||
2009 | +120.00% | ||
2008 | -86.59% | ||
2007 | -48.75% | ||
2006 | +54.44% | ||
2005 | -0.38% |
- Stock Market
- Equities
- RENE Stock
- Quotes ReNeuron Group plc